Engineering an in vitro air-blood barrier by 3D bioprinting

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Horvath, Lenke ^a   Umehara, Yuki ^a   Jud, Corinne ^a,c   Blank, Fabian ^b   Petri Fink, Alke ^a   Rothen Rutishauser, Barbara ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Institute for Livestock Sciences ILS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPRINTING; CELL COMMUNICATION; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; COCULTURE; CONFOCAL MICROSCOPY; HUMAN; LUNG GAS EXCHANGE; PHYSIOLOGY; PROCEDURES; THREE DIMENSIONAL PRINTING; TISSUE ENGINEERING;

BIOPRINTING; BLOOD-AIR BARRIER; CELL COMMUNICATION; CELL LINE; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; MICROSCOPY, CONFOCAL; PRINTING, THREE-DIMENSIONAL; TISSUE ENGINEERING;

EID: 84942297050     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07974     Document Type: Article

References (58)

1. Hartung, T., Rovida, C. Chemical regulators have overreached. Nature 460, 1080-1081, doi:10.1038/4601080a (2009).
2. Andersen, M. E. Calling on Science: Making "Alternatives" the New Gold Standard. ALTEX 27, 135-143 (2010).
3. National Research Council Toxicity Testing in the 21st Century: A Vision and a Strategy. (National Academies Press, Washington, D.C., 2007).
4. Reduce, refine, replace. Nat. Immunol. 11, 971, doi:10.1038/ni1110-971 (2010).
5. Lee, C. J., Lee, L. H.,Wu, C. L., Lee, B. R., Chen, M. L. Clinical Trials of Drugs and Biopharmaceuticals. (CRC Press, Taylor & Francis Group, Boca Raton, 2005).
6. Jud, C.,Clift, M. J., Petri-Fink, A.&Rothen-Rutishauser, B. Nanomaterials and the human lung: what is known and what must be deciphered to realise their potential advantages Swiss Med. Wkly. 143, w13758, doi:10.4414/smw.2013.13758 (2013).
7. de Souza Carvalho, C., Daum, N., Lehr, C. M. Carrier interactions with the biological barriers of the lung: Advanced in vitro models and challenges for pulmonary drug delivery. Adv. Drug Deliv. Rev. 75C, 129-140, doi:10.1016/j.addr.2014.05.014 (2014).
8. Gehr, P. et al. Endocytosis of environmental and engineered micro-and nanosized particles. Compr. Physiol. 1, 1159-1174, doi:10.1002/cphy.c100035 (2011).
9. Peters, A.,Wichmann,H. E., Tuch, T.,Heinrich, J.& Heyder, J. Respiratory effects are associated with the number of ultrafine particles. Am. J. Respir. Crit. Care Med. 155, 1376-1383, doi:10.1164/ajrccm.155.4.9105082 (1997).
10. Schulz, H. et al. Cardiovascular effects of fine and ultrafine particles. J. Aerosol Med. 18, 1-22, doi:10.1089/jam.2005.18.1 (2005).
11. Rothen-Rutishauser, B., Clift, M. J. D., Jud, C., Fink, A., Wick, P. Human epithelial cell in vitro-Are they an advantageous tool to help understand the nanomaterial-biological barrier interaction Euro Nano Tox Letters 4, 1-20 (2012).
12. Fuchs, S., Gumbleton, M., Schaefer, U. F., Lehr, C. M. [Models of the alveolar epithelium] Cell Culture Models of Biological Barriers: In vitro Test Systems for Drug Absorption and Delivery [Lehr, C. M. (ed.)] [189-210] (Taylor & Francis, London, New York, 2002).
13. Steimer, A., Haltner, E., Lehr, C. M. Cell culture models of the respiratory tract relevant to pulmonary drug delivery. J. Aerosol Med. 18, 137-182, doi:10.1089/jam.2005.18.137 (2005).
14. Hermanns, M. I., Unger, R. E., Kehe, K., Peters, K., Kirkpatrick, C. J. Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro. Lab. Invest. 84, 736-752, doi:10.1038/labinvest.3700081 (2004).
15. Klein, S.G., Serchi, T.,Hoffmann, L., Blomeke, B.&Gutleb, A. C. An improved 3D tetraculture system mimicking the cellular organisation at the alveolar barrier to study the potential toxic effects of particles on the lung. Part. Fibre Toxicol. 10, 31, doi:10.1186/1743-8977-10-31 (2013).
16. Rothen-Rutishauser, B., Blank, F., Muhlfeld, C., Gehr, P. In vitro models of the human epithelial airway barrier to study the toxic potential of particulate matter. Expert Opin. Drug Metab. Toxicol. 4, 1075-1089, doi:10.1517/17425255.4.8.1075 (2008).
17. Nichols, J. E. et al. Modeling the lung: Design and development of tissue engineered macro-and micro-physiologic lung models for research use. Exp. Biol. Med. (Maywood) 239, 1135-1169, doi:10.1177/1535370214536679 (2014).
18. Gehr, P., Bachofen, M., Weibel, E. R. The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir. Physiol. 32, 121-140 (1978).
19. Weibel, E. R. Whatmakes a good lung Swiss Med. Wkly. 139, 375-386, doi:smw-12270 (2009).
20. Huh, D. et al. Reconstituting organ-level lung functions on a chip. Science 328, 1662-1668, doi:10.1126/science.1188302 (2010).
21. Huh, D. et al. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci. Transl. Med. 4, 159-147, doi:10.1126/scitranslmed.3004249 (2012).
22. Huh, D. et al. Microfabrication of human organs-on-chips. Nat. Protoc. 8, 2135-2157, doi:10.1038/nprot.2013.137 (2013).
23. Mahto, S. K. et al. Microfluidic platforms for advanced risk assessments of nanomaterials. Nanotoxicology, 1-15, doi:10.3109/17435390.2014.940402 (2014).
24. Schurch,D. et al.Modeling nanoparticle-alveolar epithelial cell interactions under breathing conditions using captive bubble surfactometry. Langmuir 30, 4924-4932, doi:10.1021/la500307q (2014).
25. Mironov, V. et al. Biofabrication: a 21st century manufacturing paradigm. Biofabrication 1, 022001, doi:10.1088/1758-5082/1/2/022001 (2009).
26. Ozbolat, I. T.&Yu, Y. Bioprinting toward organ fabrication: challenges and future trends. IEEE Trans. Biomed. Eng. 60, 691-699, doi:10.1109/TBME.2013.2243912 (2013).
27. Tasoglu, S.&Demirci, U. Bioprinting for stem cell research. Trends Biotechnol. 31, 10-19, doi:10.1016/j.tibtech.2012.10.005 (2013).
28. Wust, S., Godla, M. E., Muller, R., Hofmann, S. Tunable hydrogel composite with two-step processing in combination with innovative hardware upgrade for cell-based three-dimensional bioprinting. Acta Biomater. 10, 630-640, doi:10.1016/j.actbio.2013.10.016 (2014).
29. Guillotin, B., Guillemot, F. Cell patterning technologies for organotypic tissue fabrication. Trends Biotechnol. 29, 183-190, doi:10.1016/j.tibtech.2010.12.008 (2011).
30. Murphy, S. V., Atala, A. 3D bioprinting of tissues and organs. Nat. Biotechnol. 32, 773-785, doi:10.1038/nbt.2958 (2014).
31. Bajaj, P., Schweller, R. M., Khademhosseini, A., West, J. L., Bashir, R. 3D biofabrication strategies for tissue engineering and regenerative medicine. Annu. Rev. Biomed. Eng. 16, 247-276, doi:10.1146/annurev-bioeng-071813-105155 (2014).
32. Seol, Y. J., Kang, H. W., Lee, S. J., Atala, A., Yoo, J. J. Bioprinting technology and its applications. Eur. J. Cardiothorac. Surg. 46, 342-348, doi:10.1093/ejcts/ezu148 (2014).
33. Duan, B., Kapetanovic, E., Hockaday, L. A., Butcher, J. T. Three-dimensional printed trileaflet valve conduits using biological hydrogels and human valve interstitial cells. Acta Biomater. 10, 1836-1846, doi:10.1016/j.actbio.2013.12.005 (2014).
34. Gaebel, R. et al. Patterning human stem cells and endothelial cells with laser printing for cardiac regeneration. Biomaterials 32, 9218-9230, doi:10.1016/j.biomaterials.2011.08.071 (2011).
35. Gaetani, R. et al. Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cells. Biomaterials 33, 1782-1790, doi:10.1016/j.biomaterials.2011.11.003 (2012).
36. Pati, F. et al. Printing three-dimensional tissue analogues with decellularized extracellular matrix bioink. Nat. Commun. 5, 3935, doi:10.1038/ncomms4935 (2014).
37. Fedorovich, N. E., De Wijn, J. R., Verbout, A. J., Alblas, J., Dhert, W. J. Threedimensional fiber deposition of cell-laden, viable, patterned constructs for bone tissue printing. Tissue Eng. Part A 14, 127-133, doi:10.1089/ten.a.2007.0158 (2008).
38. Fedorovich, N. E. et al. Biofabrication of osteochondral tissue equivalents by printing topologically defined, cell-laden hydrogel scaffolds. Tissue Eng. Part C, Methods 18, 33-44, doi:10.1089/ten.TEC.2011.0060 (2012).
39. Phillippi, J. A. et al.Microenvironments engineered by inkjet bioprinting spatially direct adult stem cells toward muscle-and bone-like subpopulations. Stem Cells 26, 127-134, doi:10.1634/stemcells.2007-0520 (2008).
40. Xu, T. et al.Hybrid printing ofmechanically and biologically improved constructs for cartilage tissue engineering applications. Biofabrication 5, 015001, doi:10.1088/1758-5082/5/1/015001 (2013).
41. Cui, X., Boland, T. Human microvasculature fabrication using thermal inkjet printing technology. Biomaterials 30, 6221-6227, doi:10.1016/j.biomaterials.2009.07.056 (2009).
42. Norotte, C.,Marga, F. S., Niklason, L. E., Forgacs, G. Scaffold-free vascular tissue engineering using bioprinting. Biomaterials 30, 5910-5917, doi:10.1016/j.biomaterials.2009.06.034 (2009).
43. Bertassoni, L. E. et al. Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs. Lab Chip 14, 2202-2211, doi:10.1039/c4lc00030g (2014).
44. Lee, W. et al. Multi-layered culture of human skin fibroblasts and keratinocytes through three-dimensional freeform fabrication. Biomaterials 30, 1587-1595, doi:10.1016/j.biomaterials.2008.12.009 (2009).
45. Marga, F. et al. Toward engineering functional organ modules by additive manufacturing. Biofabrication 4, 022001, doi:10.1088/1758-5082/4/2/022001 (2012).
46. Owens, C.M., Marga, F., Forgacs, G.&Heesch, C.M. Biofabrication and testing of a fully cellular nerve graft. Biofabrication 5, 045007, doi:10.1088/1758-5082/5/4/045007 (2013).
47. Xu, F. et al. A three-dimensional in vitro ovarian cancer coculture model using a high-throughput cell patterning platform. Biotechnol. J. 6, 204-212, doi:10.1002/biot.201000340 (2011).
48. Zhao, Y. et al. Three-dimensional printing of Hela cells for cervical tumor model in vitro. Biofabrication 6, 035001, doi:10.1088/1758-5082/6/3/035001 (2014).
49. Chang, R., Nam, J., Sun, W. Direct cell writing of 3D microorgan for in vitro pharmacokinetic model. Tissue Eng. Part C, Methods 14, 157-166, doi:10.1089/ten.tec.2007.0392 (2008).
50. Chang, R., Emami, K., Wu, H., Sun, W. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model. Biofabrication 2, 045004, doi:10.1088/1758-5082/2/4/045004 (2010).
51. Faulkner-Jones, A. et al. Development of a valve-based cell printer for the formation of human embryonic stem cell spheroid aggregates. Biofabrication 5, 015013, doi:10.1088/1758-5082/5/1/015013 (2013).
52. Rothen-Rutishauser, B. M., Kiama, S. G., Gehr, P. A three-dimensional cellular model of the human respiratory tract to study the interaction with particles. Am. J. Respir. Cell Mol. Biol. 32, 281-289, doi:10.1165/rcmb.2004-0187OC (2005).
53. Benton, G., Arnaoutova, I., George, J., Kleinman, H. K., Koblinski, J. Matrigel: From discovery and ECM mimicry to assays and models for cancer research. Adv. Drug Deliv. Rev. doi:10.1016/j.addr.2014.06.005 (2014).
54. Hughes, C. S., Postovit, L. M., Lajoie, G. A. Matrigel: a complex protein mixture required for optimal growth of cell culture. Proteomics 10, 1886-1890, doi:10.1002/pmic.200900758 (2010).
55. Fishman, A. P. et al. Fishman's Pulmonary Diseases and Disorders (The McGraw-Hill Companies, New York, 2008).
56. Lieber, M., Smith, B., Szakal, A., Nelson-Rees, W., Todaro, G. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int. J. Cancer 17, 62-70 (1976).
57. Edgell, C. J., McDonald, C. C., Graham, J. B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U. S. A. 80, 3734-3737 (1983).
58. Velarde, G. et al. Use of transepithelial electrical resistance in the study of pentachlorophenol toxicity. Toxicol. In Vitro 13, 723-727 (1999).